Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| Yesterday 6:44 PM View:  | York Charles N II COO, CFO and Secretary | Day One Biopharmaceuticals,... (DAWN) | Yesterday | Sale (Planned) | 8,078 | $17.85 | $144,214.00 | (4%) 225.37K to 217.29K | |
| Yesterday 6:48 PM View: | Bender Jeremy Chief Executive Officer Director | Day One Biopharmaceuticals,... (DAWN) | Yesterday | Sale (Planned) | 9,154 | $17.85 | $163,417.00 | (< 1%) 1.7M to 1.69M | |
| Yesterday 6:44 PM View: | York Charles N II COO, CFO and Secretary | Day One Biopharmaceuticals,... (DAWN) | 02-May-24 | Sale (Planned) | 200 | $17.90 | $3,579.10 | (< 1%) 225.57K to 225.37K | |
| Yesterday 6:48 PM View: | Bender Jeremy Chief Executive Officer Director | Day One Biopharmaceuticals,... (DAWN) | 02-May-24 | Sale (Planned) | 6 | $17.94 | $107.62 | (< 1%) 1.7M to 1.7M | |
| Yesterday 6:44 PM View: | York Charles N II COO, CFO and Secretary | Day One Biopharmaceuticals,... (DAWN) | 01-May-24 | Private Sale (Planned) | 52,183 | $17.89 | $933,397.00 | (19%) 277.75K to 225.57K | |
| Yesterday 6:48 PM View: | Bender Jeremy Chief Executive Officer Director | Day One Biopharmaceuticals,... (DAWN) | 01-May-24 | Private Sale (Planned) | 70,051 | $17.88 | $1,252,180.00 | (4%) 1.77M to 1.7M | |
| 22-Apr-24 6:36 PM View: | Blackman Samuel C. HEAD OF R&D | Day One Biopharmaceuticals,... (DAWN) | 18-Apr-24 | Market Sale (Planned) | 10,000 | $16.02 | $160,163.00 | (< 1%) 2.18M to 2.17M | 10% |
| 26-Mar-24 6:09 PM View: | Blackman Samuel C. HEAD OF R&D | Day One Biopharmaceuticals,... (DAWN) | 25-Mar-24 | Market Sale (Planned) | 10,000 | $16.01 | $160,055.00 | (< 1%) 2.19M to 2.18M | 10% |
| 13-Mar-24 4:24 PM View: | Blackman Samuel C. HEAD OF R&D | Day One Biopharmaceuticals,... (DAWN) | 11-Mar-24 | Market Sale (Planned) | 30,000 | $15.24 | $457,314.00 | (1%) 2.22M to 2.19M | 5% |
| 28-Feb-24 7:55 PM View: | Blackman Samuel C. HEAD OF R&D | Day One Biopharmaceuticals,... (DAWN) | 27-Feb-24 | Market Sale (Planned) | 20,000 | $16.11 | $322,166.00 | (< 1%) 2.24M to 2.22M | 10% |
| 20-Feb-24 6:48 PM View: | Dubow Adam General Counsel | Day One Biopharmaceuticals,... (DAWN) | 16-Feb-24 | Option Sale | 3,242 | $15.25 | $49,434.30 | (16%) 19.83K to 16.59K | |
| 20-Feb-24 6:36 PM View: | York Charles N II COO, CFO and Secretary | Day One Biopharmaceuticals,... (DAWN) | 16-Feb-24 | Option Sale | 2,666 | $15.25 | $40,651.40 | (< 1%) 280.42K to 277.75K | |
| 20-Feb-24 6:14 PM View: | Bender Jeremy Chief Executive Officer Director | Day One Biopharmaceuticals,... (DAWN) | 16-Feb-24 | Option Sale | 7,615 | $15.25 | $116,114.00 | (< 1%) 1.77M to 1.77M | |
| 20-Feb-24 6:26 PM View: | Blackman Samuel C. Head of Research and Developme | Day One Biopharmaceuticals,... (DAWN) | 16-Feb-24 | Option Sale | 2,258 | $15.25 | $34,430.20 | (< 1%) 2.25M to 2.24M | |
| 20-Feb-24 6:36 PM View: | York Charles N II COO, CFO and Secretary | Day One Biopharmaceuticals,... (DAWN) | 15-Feb-24 | Option Exercise | 10,250 | -- | -- | 4% 270.17K to 280.42K | |
| 20-Feb-24 6:14 PM View: | Bender Jeremy Chief Executive Officer Director | Day One Biopharmaceuticals,... (DAWN) | 15-Feb-24 | Option Exercise | 19,999 | -- | -- | 1% 1.75M to 1.77M | |
| 20-Feb-24 6:26 PM View: | Blackman Samuel C. Head of Research and Developme | Day One Biopharmaceuticals,... (DAWN) | 15-Feb-24 | Option Exercise | 8,686 | -- | -- | < 1% 2.24M to 2.25M | |
| 20-Feb-24 6:48 PM View: | Dubow Adam General Counsel | Day One Biopharmaceuticals,... (DAWN) | 15-Feb-24 | Option Exercise | 8,399 | -- | -- | 73% 11.43K to 19.83K | |
| 17-Nov-23 6:33 PM View: | York Charles N II COO, CFO and Secretary | Day One Biopharmaceuticals,... (DAWN) | 16-Nov-23 | Option Sale | 956 | $11.69 | $11,175.60 | (< 1%) 271.13K to 270.17K | |
| 17-Nov-23 6:20 PM View: | Bender Jeremy Chief Executive Officer Director | Day One Biopharmaceuticals,... (DAWN) | 16-Nov-23 | Option Sale | 3,107 | $11.69 | $36,320.80 | (< 1%) 1.76M to 1.75M | |
| 17-Nov-23 6:26 PM View: | Blackman Samuel C. Head of Research and Developme | Day One Biopharmaceuticals,... (DAWN) | 16-Nov-23 | Option Sale | 709 | $11.69 | $8,288.21 | (< 1%) 2.24M to 2.24M | |
| 17-Nov-23 6:30 PM View: | Dubow Adam General Counsel | Day One Biopharmaceuticals,... (DAWN) | 16-Nov-23 | Option Sale | 5,313 | $11.69 | $62,109.00 | (32%) 16.74K to 11.43K | |
| 17-Nov-23 6:30 PM View: | Dubow Adam General Counsel | Day One Biopharmaceuticals,... (DAWN) | 15-Nov-23 | Option Exercise | 13,600 | -- | -- | 433% 3.14K to 16.74K | |
| 17-Nov-23 6:33 PM View: | York Charles N II COO, CFO and Secretary | Day One Biopharmaceuticals,... (DAWN) | 15-Nov-23 | Option Exercise | 3,625 | -- | -- | 1% 267.5K to 271.13K | |
| 17-Nov-23 6:20 PM View: | Bender Jeremy Chief Executive Officer Director | Day One Biopharmaceuticals,... (DAWN) | 15-Nov-23 | Option Exercise | 8,312 | -- | -- | < 1% 1.75M to 1.76M | |
| 17-Nov-23 6:26 PM View: | Blackman Samuel C. Head of Research and Developme | Day One Biopharmaceuticals,... (DAWN) | 15-Nov-23 | Option Exercise | 2,624 | -- | -- | < 1% 2.24M to 2.24M | |
| 20-Oct-23 4:02 PM View: | Ai Day 1 LLC 10% Owner | Day One Biopharmaceuticals,... (DAWN) | 20-Oct-23 | Purchase | 111,387 | $9.97 | $1,110,910.00 | < 1% 12.82M to 12.93M | |
| 20-Oct-23 4:02 PM View: | Ai Day 1 LLC 10% Owner | Day One Biopharmaceuticals,... (DAWN) | 19-Oct-23 | Purchase | 384,400 | $10.06 | $3,867,370.00 | 3% 12.43M to 12.82M | |
| 20-Oct-23 4:02 PM View: | Ai Day 1 LLC 10% Owner | Day One Biopharmaceuticals,... (DAWN) | 18-Oct-23 | Private Purchase | 979,667 | $10.21 | $10,000,000.00 | 9% 11.45M to 12.43M | |
| 17-Aug-23 7:02 PM View: | York Charles N II COO, CFO and Secretary | Day One Biopharmaceuticals,... (DAWN) | 17-Aug-23 | Option Sale | 922 | $13.86 | $12,778.90 | (< 1%) 268.42K to 267.5K | |
| 17-Aug-23 6:16 PM View: | Bender Jeremy Chief Executive Officer Director | Day One Biopharmaceuticals,... (DAWN) | 17-Aug-23 | Option Sale | 2,996 | $13.86 | $41,524.60 | (< 1%) 1.75M to 1.75M | |
| 17-Aug-23 6:21 PM View: | Blackman Samuel C. Head of Research and Developme | Day One Biopharmaceuticals,... (DAWN) | 17-Aug-23 | Option Sale | 668 | $13.86 | $9,258.48 | (< 1%) 2.24M to 2.24M | |
| 17-Aug-23 6:21 PM View: | Blackman Samuel C. Head of Research and Developme | Day One Biopharmaceuticals,... (DAWN) | 15-Aug-23 | Option Exercise | 2,624 | -- | -- | < 1% 2.23M to 2.24M | |
| 17-Aug-23 7:02 PM View: | York Charles N II COO, CFO and Secretary | Day One Biopharmaceuticals,... (DAWN) | 15-Aug-23 | Option Exercise | 3,625 | -- | -- | 1% 264.8K to 268.42K | |
| 17-Aug-23 6:16 PM View: | Bender Jeremy Chief Executive Officer Director | Day One Biopharmaceuticals,... (DAWN) | 15-Aug-23 | Option Exercise | 8,312 | -- | -- | < 1% 1.74M to 1.75M | |
| 05-Jul-23 10:00 PM View: | Bender Jeremy Chief Executive Officer Director | Day One Biopharmaceuticals,... (DAWN) | 01-Jul-23 | Gift | 329,963 | -- | -- | (14%) 2.31M to 1.98M | |
| 05-Jul-23 10:00 PM View: | Bender Jeremy Chief Executive Officer Director | Day One Biopharmaceuticals,... (DAWN) | 01-Jul-23 | Gift | 570,251 | -- | -- | 33% 1.74M to 2.31M | |
| 05-Jul-23 10:00 PM View: | Bender Jeremy Chief Executive Officer Director | Day One Biopharmaceuticals,... (DAWN) | 01-Jul-23 | Acquisition (other) | 240,288 | -- | -- | 10% 2.31M to 2.55M | |
| 05-Jul-23 10:00 PM View: | Bender Jeremy Chief Executive Officer Director | Day One Biopharmaceuticals,... (DAWN) | 01-Jul-23 | Gift | 240,288 | -- | -- | (9%) 2.55M to 2.31M | |
| 05-Jul-23 10:00 PM View: | Bender Jeremy Chief Executive Officer Director | Day One Biopharmaceuticals,... (DAWN) | 01-Jul-23 | Disposition (other) | 240,288 | -- | -- | (12%) 1.98M to 1.74M | |
| 12-Jun-23 4:03 PM View: | Ai Day 1 LLC 10% Owner | Day One Biopharmaceuticals,... (DAWN) | 09-Jun-23 | Private Purchase | 769,230 | $13.00 | $9,999,990.00 | 7% 10.68M to 11.45M | |
| 07-Jun-23 4:51 PM View: | Blackman Samuel C. Chief Medical Officer | Day One Biopharmaceuticals,... (DAWN) | 05-Jun-23 | Market Sale (Planned) | 1,229 | $16.00 | $19,664.00 | (< 1%) 2.24M to 2.23M | 9% |
| 17-May-23 6:27 PM View: | Bender Jeremy Chief Executive Officer Director | Day One Biopharmaceuticals,... (DAWN) | 16-May-23 | Option Sale | 3,104 | $13.12 | $40,731.60 | (< 1%) 1.75M to 1.74M | |
| 17-May-23 6:31 PM View: | Blackman Samuel C. Chief Medical Officer | Day One Biopharmaceuticals,... (DAWN) | 16-May-23 | Option Sale | 692 | $13.12 | $9,080.63 | (< 1%) 2.24M to 2.24M | |
| 17-May-23 6:36 PM View: | York Charles N II COO, CFO and Secretary | Day One Biopharmaceuticals,... (DAWN) | 16-May-23 | Option Sale | 955 | $13.12 | $12,531.80 | (< 1%) 265.75K to 264.8K | |
| 17-May-23 6:36 PM View: | York Charles N II COO, CFO and Secretary | Day One Biopharmaceuticals,... (DAWN) | 15-May-23 | Option Exercise | 3,625 | -- | -- | 1% 262.13K to 265.75K | |
| 17-May-23 6:27 PM View: | Bender Jeremy Chief Executive Officer Director | Day One Biopharmaceuticals,... (DAWN) | 15-May-23 | Option Exercise | 8,312 | -- | -- | < 1% 1.74M to 1.75M | |
| 17-May-23 6:31 PM View: | Blackman Samuel C. Chief Medical Officer | Day One Biopharmaceuticals,... (DAWN) | 15-May-23 | Option Exercise | 2,624 | -- | -- | < 1% 2.23M to 2.24M | |
| 14-Mar-23 6:19 PM View: | Blackman Samuel C. Chief Medical Officer | Day One Biopharmaceuticals,... (DAWN) | 10-Mar-23 | Private Sale (Planned) | 10,000 | $18.05 | $180,484.00 | (< 1%) 2.24M to 2.23M | |
| 08-Mar-23 5:50 PM View: | Bender Jeremy Chief Executive Officer Director | Day One Biopharmaceuticals,... (DAWN) | 07-Mar-23 | Private Sale (Planned) | 12,500 | $20.01 | $250,114.00 | (< 1%) 1.75M to 1.74M |
